Perkins Capital Management Inc
Source: SEC Form 13F · as of Mar 2026Perkins Capital Management Inc holds 28 biotech & pharma companies tracked by BioSniper, totaling $35.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
28
Total value held
$35.6M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 8,830 | $8.1M |
| IDXXIDEXX LABORATORIES INC /DE | 9,700 | $5.5M |
| MDXHMDxHealth SA | 1,476,441 | $3.4M |
| ABTABBOTT LABORATORIES | 20,659 | $2.1M |
| CYRXCryoport, Inc. | 203,247 | $1.7M |
| NEOGNEOGEN CORP | 178,000 | $1.7M |
| LUCDLucid Diagnostics Inc. | 1,126,000 | $1.3M |
| ABBVAbbVie Inc. | 5,342 | $1.2M |
| PFEPFIZER INC | 35,909 | $1.0M |
| GILDGILEAD SCIENCES, INC. | 7,216 | $1.0M |
| NEONeoGenomics Inc. | 132,350 | $982K |
| MRKMerck & Co., Inc. | 7,750 | $932K |
| TLSITriSalus Life Sciences Inc. | 230,101 | $920K |
| TELATELA Bio Inc. | 1,418,328 | $879K |
| VTRSViatris Inc | 54,895 | $742K |
| PROFProfound Medical Corp. | 114,280 | $741K |
| BDSXBiodesix Inc. | 44,783 | $649K |
| ANIPANI PHARMACEUTICALS INC | 7,841 | $603K |
| BMYBRISTOL MYERS SQUIBB CO | 7,430 | $451K |
| CSTLCastle Biosciences Inc. | 15,415 | $378K |
| VCELVericel Corp | 10,450 | $336K |
| LFVNLifevantage Corp | 75,458 | $326K |
| JNJJOHNSON & JOHNSON | 1,200 | $293K |
| MRNAModerna, Inc. | 4,000 | $203K |
| PBYIPUMA BIOTECHNOLOGY, INC. | 12,500 | $80K |
| RMTIROCKWELL MEDICAL, INC. | 70,371 | $63K |
| SOPHSOPHiA GENETICS SA | 10,500 | $52K |
| DYAIDYADIC INTERNATIONAL INC | 48,050 | $39K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.